Comparative study of anticoagulation therapy with an LVAD system.
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D001243:Assisted Circulation; D001550:Benzamidines; D016861:Cyclooxygenase Inhibitors; D004285:Dogs; D011464:Epoprostenol / Q000627:therapeutic use / Q000031:analogs & derivatives; D005340:Fibrinogen / Q000032:analysis; D006146:Guanidines / Q000627:therapeutic use; D006353:Heart-Assist Devices; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008689:Methacrylates / Q000627:therapeutic use; D010314:Partial Thromboplastin Time; D010974:Platelet Aggregation / Q000187:drug effects; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D011474:Prosthesis Design; D011480:Protease Inhibitors / Q000627:therapeutic use
D000925:Anticoagulants; D001550:Benzamidines; D016861:Cyclooxygenase Inhibitors; D006146:Guanidines; D008689:Methacrylates; D011465:Prostaglandins, Synthetic; D011480:Protease Inhibitors; D005340:Fibrinogen; D011464:Epoprostenol; C034364:ozagrel; C035847:ataprost; C032855:nafamostat